Opendata, web and dolomites


A disruptive technology for vaccines manufacturing based on Self-Assembled Polymeric Nanoparticulate systems

Total Cost €


EC-Contrib. €






 SAP-Nano project word cloud

Explore the words cloud of the SAP-Nano project. It provides you a very rough idea of what is the project "SAP-Nano" about.

nanotechnology    economic    easily    marketing    faced    thorough    presented    scalable    losses    solved    lower    industrial    verify    inexpensive    sme    patented    met    manufacturer    pharmaceutical    usa    ensures    requirement    664    submission    solvents    performed    market    nanoparticle    nano    opportunity    strategies    minimize    total    launch    commercial    manufacturing    impossible    million    versatile    suitable    12    conventional    2015    standard    bionanoplus    billion    feasibility    company    nmp    perform    laboratory    volatile    prrsv    molecules    manufacturers    vaccines    successfully    swine    viability    significantly    seemed    clients    instrument    avoiding    techniques    plan    evaluation    issue    21    fish    sap    firstly    organic    usd    costly    cosmetic    veterinary    11    risks    antigens    move    encapsulate    84    scalability    detected    model    first    time    business    industry    score    eur    point    25   

Project "SAP-Nano" data sheet

The following table provides information about the project.


Organization address
city: NOAIN
postcode: 31110
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Project website
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.1.5. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced manufacturing and processing)
2. H2020-EU.2.1.3. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced materials)
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.2.1.2. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2016
 Duration (year-month-day) from 2016-06-01   to  2016-11-30


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    BIONANOPLUS SL ES (NOAIN) coordinator 50˙000.00


 Project objective

Bionanoplus detected the major problems faced by many pharmaceutical, veterinary and cosmetic sector manufacturers to develop products using nanotechnology. It seemed impossible and costly to move a product developed in the laboratory to the industrial manufacturing of the product. To solve this issue Bionanoplus has developed and patented a highly versatile and easily scalable technology to encapsulate antigens and other molecules, called SAP-Nano. Bionanoplus has solved the scalability problem of traditional nanoparticle manufacturing methods avoiding the use of volatile organic solvents, thus it ensures an easy and inexpensive production of any scale, which can be performed using standard equipment and techniques. SAP-Nano technology has been successfully implemented with two clients, a fish vaccines manufacturer and a pharmaceutical company. Now Bionanoplus plan to launch his technology in the vaccines manufacturers market, firstly on to the PRRSV vaccines manufacturers market. It was estimated that losses due to PRRSV cost the swine industry EUR 1.5 billion per year in Europe and USD 664 million per year in the USA. SAP-Nano enables the development of unique vaccines, which are significantly more effective than conventional vaccines. Phase 1 of SME Instrument represents an opportunity to get a thorough business plan to minimize risks. The main objective is to perform a feasibility study to verify the economic viability in the vaccines manufacturers market and design a suitable business model, and the commercial, marketing and industrial strategies. The SAP-Nano proposal was presented for the first time to the 25-11-2015 call (NMP-25-2015-1-P) achieving a total score of 12,84. The lower point in the evaluation was Impact (score: 4.21). B has met potential clients in order to know the needs and requirement to develop new vaccines. The business case has also been improved. This new information has been included in this new submission of the proposal.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SAP-NANO" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SAP-NANO" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.5.;H2020-EU.2.1.3.;H2020-EU.2.3.1.;H2020-EU.2.1.2.)

denovoSkin (2018)

Personalized, bio-engineered skin grafts for the permanent treatment of skin defects.

Read More  


New ElectroSTATIC Spraying Process of Two-Component, Solvent-Free, Fast-Curing, Liquid Resins

Read More  

HelpingHAND (2018)

A 3D printed, affordable myoelectrical prosthetic hand of personalizeable size for optimal comfort and functionality

Read More